Hyperion Therapeutics
ID: 5290447A biopharmaceutical company focused on developing treatments for urea cycle disorders and other rare diseases
3
Funding Rounds
$117.5m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma** Bl****** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Hyperion Therapeutics has raised a total of $117.47m in funding over 3 rounds.
Key Insights:
- Hyperion Therapeutics funding round, April 2011: $17.47m
- Hyperion Therapeutics Series C round: $60m
- Hyperion Therapeutics Series B round: $40m
Industries
Hyperion Therapeutics is active in the following industries: